Fatty acid amide hydrolase (FAAH) is an integral membrane protein that participates in termination of cannabinoid signalling mechanisms by catalysing the hydrolysis and thus inactivation of the endogenous cannabinoid anandamide and other natural lipids involved in signalling. Inhibition of FAAH activity, which increases the anandamide levels, is implicated in the treatment of pain, inflammation and many other disorders. Therefore, compounds that inhibit this enzyme are of medical and therapeutic significance. The aim of the current work is to create an optical biosensor in order to test substrate/inhibitor effects of FAAH. Mutants of the rat FAAH protein (rFAAH) were engineered with unique surface accessible cysteine residues for site-specific labelling with fluorescent probes. The cysteine mutations (C269S and C299S) were introduced in regions of the FAAH protein where structural changes occur upon ligand/inhibitor binding. Both mutants and the wild type protein were purified from the membrane fractions after expression in E. coli BL21. Yields of about 1mg of pure protein per litre of culture were obtained for wild type and both mutants. The activity of the purified proteins was measured using aminomethyl coumarin arachidonoyl amide (AMC-AA) as the substrate. This substrate upon hydrolysis releases the fluorescent AMC whose emission was measured at 445nm. A selected group of Cysteine-specific fluorescence probes were tested for labeling of the mutants. Labeling experiments were carried out with 10x molar excess of the probe at 4C for 1-3 hrs. Excess label was removed by gel filtration and the labeling ratio measured spectrophotometrically. Samples with labeling ratios of around 1 were then tested for inhibition of the FAAH activity. Data will be presented on the fluorescence intensity changes upon titration with the strong FAAH inhibitor, MAFP (methyl arachidonyl fluorophosphonate). These preliminary data provide the basis for a reagentless sensor of FAAH.

A reagentless sensor based on fatty acid amide hydrolase / F. Jabbour; F. Valetti; G. Mei; A. Di Venere; E. Dainese; M. Maccarrone; G. Gilardi; S.J. Sadeghi. - In: THE FEBS JOURNAL. - ISSN 1742-464X. - 278(2011), pp. 158-158. ((Intervento presentato al convegno 36th FEBS Congress-Biochemistry for tomorrow's medicine tenutosi a Torino nel 25-30 June 2011.

A reagentless sensor based on fatty acid amide hydrolase

VALETTI, Francesca;GILARDI, Gianfranco;SADEGHI, JILA
2011

Abstract

Fatty acid amide hydrolase (FAAH) is an integral membrane protein that participates in termination of cannabinoid signalling mechanisms by catalysing the hydrolysis and thus inactivation of the endogenous cannabinoid anandamide and other natural lipids involved in signalling. Inhibition of FAAH activity, which increases the anandamide levels, is implicated in the treatment of pain, inflammation and many other disorders. Therefore, compounds that inhibit this enzyme are of medical and therapeutic significance. The aim of the current work is to create an optical biosensor in order to test substrate/inhibitor effects of FAAH. Mutants of the rat FAAH protein (rFAAH) were engineered with unique surface accessible cysteine residues for site-specific labelling with fluorescent probes. The cysteine mutations (C269S and C299S) were introduced in regions of the FAAH protein where structural changes occur upon ligand/inhibitor binding. Both mutants and the wild type protein were purified from the membrane fractions after expression in E. coli BL21. Yields of about 1mg of pure protein per litre of culture were obtained for wild type and both mutants. The activity of the purified proteins was measured using aminomethyl coumarin arachidonoyl amide (AMC-AA) as the substrate. This substrate upon hydrolysis releases the fluorescent AMC whose emission was measured at 445nm. A selected group of Cysteine-specific fluorescence probes were tested for labeling of the mutants. Labeling experiments were carried out with 10x molar excess of the probe at 4C for 1-3 hrs. Excess label was removed by gel filtration and the labeling ratio measured spectrophotometrically. Samples with labeling ratios of around 1 were then tested for inhibition of the FAAH activity. Data will be presented on the fluorescence intensity changes upon titration with the strong FAAH inhibitor, MAFP (methyl arachidonyl fluorophosphonate). These preliminary data provide the basis for a reagentless sensor of FAAH.
36th FEBS Congress-Biochemistry for tomorrow's medicine
Torino
25-30 June 2011
278
158
158
Fatty Acid Amide Hydrolase; BIOSENSOR; fluorescence
F. Jabbour; F. Valetti; G. Mei; A. Di Venere; E. Dainese; M. Maccarrone; G. Gilardi; S.J. Sadeghi
File in questo prodotto:
File Dimensione Formato  
Abstract-Fadi .pdf

Accesso aperto

Tipo di file: MATERIALE NON BIBLIOGRAFICO
Dimensione 50.22 kB
Formato Adobe PDF
50.22 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/91370
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact